Caseware UK (AP4) 2024.0.164 2024.0.164 2024-11-302024-11-302023-12-010trueFunding of innovation and R&D projectstruefalse0The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 10249998 2023-11-30 10249998 2023-12-01 2024-11-30 10249998 2022-07-01 2023-06-30 10249998 2024-11-30 10249998 2023-06-30 10249998 c:Director1 2023-12-01 2024-11-30 10249998 d:CurrentFinancialInstruments 2024-11-30 10249998 d:CurrentFinancialInstruments 2023-06-30 10249998 d:CurrentFinancialInstruments d:WithinOneYear 2024-11-30 10249998 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 10249998 d:ShareCapital 2024-11-30 10249998 d:ShareCapital 2023-06-30 10249998 d:SharePremium 2023-12-01 2024-11-30 10249998 d:SharePremium 2024-11-30 10249998 d:SharePremium 2023-06-30 10249998 d:RetainedEarningsAccumulatedLosses 2023-12-01 2024-11-30 10249998 d:RetainedEarningsAccumulatedLosses 2024-11-30 10249998 d:RetainedEarningsAccumulatedLosses 2023-06-30 10249998 c:OrdinaryShareClass1 2023-12-01 2024-11-30 10249998 c:OrdinaryShareClass1 2024-11-30 10249998 c:OrdinaryShareClass1 2023-06-30 10249998 c:EntityNoLongerTradingButTradedInPast 2023-12-01 2024-11-30 10249998 c:FRS102 2023-12-01 2024-11-30 10249998 c:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 10249998 c:FullAccounts 2023-12-01 2024-11-30 10249998 c:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 10249998 e:PoundSterling 2023-12-01 2024-11-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 10249998









MEDTECH ACCELERATOR LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 NOVEMBER 2024

 
MEDTECH ACCELERATOR LIMITED
REGISTERED NUMBER: 10249998

BALANCE SHEET
AS AT 30 NOVEMBER 2024

2024
2023
Note
£
£

FIXED ASSETS
  

Investments
 4 
125,000
349,796

  
125,000
349,796

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
-
444

Cash at bank and in hand
  
15,237
67,911

  
15,237
68,355

Creditors: amounts falling due within one year
 6 
(6,744)
(10,254)

NET CURRENT ASSETS
  
 
 
8,493
 
 
58,101

TOTAL ASSETS LESS CURRENT LIABILITIES
  
133,493
407,897

  

NET ASSETS
  
133,493
407,897


CAPITAL AND RESERVES
  

Called up share capital 
 7 
25
25

Share premium account
 8 
1,999,980
1,999,980

Profit and loss account
 8 
(1,866,512)
(1,592,108)

  
133,493
407,897


Page 1

 
MEDTECH ACCELERATOR LIMITED
REGISTERED NUMBER: 10249998
    
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




A D Blackwood
Director

Date: 25 July 2025

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
MEDTECH ACCELERATOR LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

1.


GENERAL INFORMATION

Medtech Accelerator Limited is a private company limited by shares incorportated in the United Kingdom
under the Companies' Act 2006, and is registered in England and Wales. The address of the registered office is St John's Innovation Centre, Cowley Road, Cambridge, England, CB4 0WS. The nature of the Company's operations and its principal activities are set out in the directors' report.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

ASSOCIATES AND JOINT VENTURES

Associates and Joint Ventures are held at cost less impairment.

 
2.3

DEBTORS

Short-term debtors are measured at transaction price, less any impairment.

 
2.4

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.5

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities  are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


EMPLOYEES

The Company has no employees other than the directors, who did not receive any remuneration (2023 - £NIL).

Page 3

 
MEDTECH ACCELERATOR LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

4.


FIXED ASSET INVESTMENTS





Investments in associates

£



COST OR VALUATION


At 1 December 2023
349,796



At 30 November 2024

349,796



IMPAIRMENT


Charge for the period
224,796



At 30 November 2024

224,796



NET BOOK VALUE



At 30 November 2024
125,000



At 30 November 2023
349,796


5.


DEBTORS

2024
2023
£
£


Prepayments and accrued income
-
444

-
444



6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024
2023
£
£

Trade creditors
-
6,829

Accruals and deferred income
6,744
3,425

6,744
10,254


Page 4

 
MEDTECH ACCELERATOR LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

7.


SHARE CAPITAL

2024
2023
£
£
ALLOTTED, CALLED UP AND FULLY PAID



2,500,000 (2023 - 2,500,000) Ordinary shares of £0.00001 each
25
25



8.


RESERVES

Share premium account

Amount subscribed for share capital in excess of nominal value.

Profit and loss account

Profit and loss account includes all current and prior period retained profits and losses.

 
Page 5